somatropin + somatropin + somatropin
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Foetal Growth Problem
Conditions
Foetal Growth Problem, Small for Gestational Age
Trial Timeline
Apr 30, 2000 → Apr 30, 2003
NCT ID
NCT01734447About somatropin + somatropin + somatropin
somatropin + somatropin + somatropin is a approved stage product being developed by Novo Nordisk for Foetal Growth Problem. The current trial status is completed. This product is registered under clinical trial identifier NCT01734447. Target conditions include Foetal Growth Problem, Small for Gestational Age.
What happened to similar drugs?
2 of 6 similar drugs in Foetal Growth Problem were approved
Approved (2) Terminated (0) Active (4)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01734447 | Approved | Completed |
Competing Products
8 competing products in Foetal Growth Problem
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| somatropin | Novo Nordisk | Phase 3 | 40 |
| somatropin | Novo Nordisk | Phase 3 | 40 |
| somatropin | Novo Nordisk | Pre-clinical | 26 |
| somatropin + somatropin | Novo Nordisk | Phase 3 | 40 |
| somatropin | Novo Nordisk | Approved | 43 |
| somatropin | Novo Nordisk | Phase 3 | 40 |
| somatropin + somatropin | Novo Nordisk | Approved | 43 |
| somatropin + No treatment given + No treatment given | Novo Nordisk | Pre-clinical | 26 |